INNOVADERM CRO IS NOW INDERO.

Systemic Sclerosis Case Study

Indero

Indero

Team of Experts

Author picture

Click here for a PDF version of this case study

Indero helped optimize recruitment and logistics for this systemic sclerosis (SSc) study.

Outcomes

  1. Effective study design and patient management leading to 96% patient retention
  2. Patient recruitment was completed on time without any advertisement despite longer timelines associated with academic sites and the institutional burden

 

Study Characteristics

  • Disease focus: Systemic sclerosis (SSc), including subgroups Raynaud’s phenomenon (RP), limited cutaneous SSc (lcSSc), and diffuse cutaneous SSc (dcSSc)
  • Patient demographics: 49 patients with diverse geographic distribution
  • Study design: Biopsy-based research requiring 2 or 4 x 3mm biopsies per patient; no treatment was offered as part of the study

 

Study Challenges & Solutions

Challenge #1 – Recruitment

The absence of an active treatment arm made the study less appealing to potential participants.

Solution: Indero leveraged the site’s comprehensive patient database to identify and recruit eligible patients.

Challenge #2 – Logistics

  • Many participants traveled long distances for study visits, with some living more than 2 hours away.
  • Biopsies were conducted at a separate institute, requiring patients to attend 2 locations at each visit.

Solution: Indero successfully coordinated complex logistics, including transportation support for patients from remote areas and seamless scheduling across multiple facilities.

Need help with your next rheumatology study?

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.